![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 17, 14400-14407, April 26, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Unité de Chimie Organique, CNRS Unité de
Recherche Associée 2128, Institut Pasteur, 25-28 rue du
Dr. Roux, 75724 Paris cedex 15, France
Received for publication, December 17, 2001
Lactobacillus helveticus contains two
types of N-deoxyribosyltransferases: DRTase I catalyzes the
transfer of 2'-deoxyribose between purine bases exclusively whereas
DRTase II is able to transfer the 2'-deoxyribose between two pyrimidine
or between pyrimidine and purine bases. An Escherichia coli
strain, auxotrophic for guanine and unable to use deoxyguanosine
as source of guanine, was constructed to clone the corresponding genes.
By screening a genomic bank for the production of guanine, the L. helveticus ptd and ntd genes coding for DRTase I and
II, respectively, were isolated. Although the two genes have no
sequence similarity, the two deduced polypeptides display 25.6%
identity, with most of the residues involved in substrate binding and
the active site nucleophile Glu-98 being conserved.
Overexpression and purification of the two proteins shows that DRTase I
is specific for purines with a preference for deoxyinosine (dI) > deoxyadenosine > deoxyguanosine as donor substrates whereas
DRTase II has a strong preference for pyrimidines as donor substrates
and purines as base acceptors. Purine analogues were substrates as
acceptor bases for both enzymes. Comparison of DRTase I and DRTase II
activities with dI as donor or hypoxanthine as acceptor and
colocalization of the ptd and add genes suggest
a specific role for DRTase I in the metabolism of dI.
Lactobacilli can be empirically divided into two categories
depending on whether or not they require deoxyribonucleosides for
growth. The Lactobacillus species having an absolute
requirement for one deoxyribonucleoside, a purine, and a pyrimidine
base have evolved salvage pathways to scavenge exogenous
deoxyribonucleosides for their DNA synthesis. These species do not
contain nucleoside phosphorylases but
N-deoxyribosyltransferase and deoxyribonucleoside kinases
(1). N-Deoxyribosyltransferase, also called
trans-N-deoxyribosylase, was first discovered by McNutt (2)
in Lactobacillus helveticus and purified by Roush and Betz
(3). Holguin and Cardinaud (4) purified by affinity chromatography two
types of activities: DRTase I, specific of the transfer of deoxyribose
between two purines (Pur The L. leichmannii ntd gene, coding for DRTase II, was
cloned and the protein overexpressed in Escherichia coli
(12). NDT is a hexamer composed of six subunits of 18 kDa with an
active site located in a pocket formed by two subunits (12-14).
Although DRTase II was extensively studied, DRTase I was
only characterized biochemically (5) and partially purified (4, 15).
Here, we report the cloning of the L. helveticus ptd (coding
for DRTase I) and ntd (coding for DRTase II)
genes by restoration of the guanine auxotrophy of a Growth of Bacterial Strains--
The strains and plasmids used
for this study are listed in Table I.
Bacteria were routinely grown in MS minimal medium (16) or in LB medium
(17). Nucleosides and deoxynucleosides when necessary were added at a
final concentration of 0.3 mM. Antibiotics were added at
the following concentrations: gentamicin and tetracycline (10 µg/ml),
ampicillin (100 µg/ml), and chloramphenicol and kanamycin (25 µg/ml).
Construction of Strain PAK6: MG1655
Construction of Strain PAK26: MG1655 Construction of the L. helveticus Genomic DNA Bank--
L.
helveticus CNRZ32 DNA was prepared from an exponential phase
culture. Cells were lysed in TES buffer (Tris, 50 mM (pH
8); EDTA, 10 mM (pH 8); saccharose, 250 mM)
containing 20 µg/ml lysozyme and 50 units/ml mutanolysine (Sigma
Chemical Co.). After a 1-h incubation at 37 °C, SDS to a final
concentration to 2% was added and the mixture was extracted three
times with phenol/chloroform/isoamyl alcohol. After precipitation, the
DNA was resuspended in RNase A (500 µg/ml) containing water and
partially digested with the AluI restriction enzyme. After
migration on a 0.8% agarose gel the 1-, 1.5-, and 2-kb AluI
DNA fragments were isolated using the Qiagel extraction kit (Qiagen).
The DNA fragments were then ligated into the pBAM3 plasmid digested
with the restriction enzyme SmaI whose 5' extremities were
dephosphorylated with alkaline phosphatase. After an incubation of
16 h at 16 °C, the ligation mixture was desalted on Millipore
(0.05 µm, 13 mm) filters and used to transform strain PAK6 by
electroporation according to Dower et al. (18).
Bacteria were resuspended in LB medium supplemented with guanine (0.3 mM) and incubated 1 h at 37 °C. Cells were then washed two times with MS medium before plating on MS glucose medium (16) supplemented with ampicillin (100 µg/ml), deoxyguanosine (0.3 mM), and adenine (0.3 mM).
Preparation of Crude Extracts and Rapid Measurement of the
Deoxyribosyltransferase Activity--
Bacteria were grown overnight at
37 °C in LB medium supplemented with ampicillin (100 µg/ml) and
the appropriate nucleosides and bases depending on the strain used.
Cells were centrifuged at 4000 rpm for 15 min, washed once with a 100 mM phosphate buffer (NaH2PO4/Na2HPO4), pH
7.5, and resuspended in the same buffer at one-tenth of the original
volume. Bacteria were disrupted by sonication, and the extracts were
cleared by two successive centrifugations at 13000 rpm for 10 min at
4 °C. The lysate activity was determined by incubation of different
amounts of lysate in 20 mm of citrate buffer at pH 6.0 in the presence
of a deoxyribonucleoside (3 mM) and a base (1 mM). The reaction was followed by applying 2-µl aliquots
to a thin-layer chromatography plate for separation of substrates and
products in 80% CH2Cl2/20% methanol.
The RF of the different nucleosides and bases was
measured after visualization under UV at 254 nm. Plates were revealed
after pulverization in ethanol/p-anisaldehyde/sulfuric acid/acetic acid (90/5/5/1)
and heated at 150 °C.
Protein Overexpression and
Purification--
Oligonucleotides PAK2,
5'-NGATATACATATGAAAGCAGTAGTTCCAACAGG and PAK3,
5'-NNGGATCCTTAATAGATACCGTAACCGCG; PAK9,
5'-NGATATACATATGAACAAGAAAAAGACTTTATATTTTGG and PAK10,
5'-NNGGATCCTTAATATACAGCTCCGTCGTAG were used to
amplify the ptd and the ntd genes in a standard
PCR reaction using plasmids pLH2 or pLH4, respectively, as DNA
template. The parameters used were 1 cycle of 5 min at 95 °C; 25 cycles of 30 s at 95 °C, 30 s at 60 °C, and 1 min at
72 °C; and 1 cycle of 10 min at 72 °C. Each PCR product was
purified by using the QIAquick PCR purification kit (Qiagen) then
digested with NdeI and BamHI enzymes (underlined in the oligonucleotide sequences) over 2 h at 37 °C and
purified again with the QIAquick PCR purification kit. Each PCR product was ligated with plasmid pET24a digested with the same restriction enzymes. The ligation mixtures were used to transform strain
500 ml of LB medium inoculated with an overnight culture of
BL21(DE3)pLysS containing either pETLH2 or pETLH4 was grown under agitation at 37 °C until A600 = 0.6. Isopropyl-1-thio- Mass Spectrometry--
The mass spectrometry was performed by
the PT3 proteomique of the Pasteur Institute. Ion spray mass
spectra were recorded on an API 365 mass spectrometer (PerkinElmer Life
Sciences-Sciex, Thornhill, Canada). Samples dissolved in
water/methanol/formic acid (50/50/5) were introduced at 5 µl/min with
a syringe pump (Harvard Apparatus, South Natick, MA). The mass
spectrometer was scanned continuously from m/z 1100 to 1700 with a scan step of 0.1 and a dwell time per step of 2.0 ms, resulting
in a scan duration of 16.0 s. Data were collected on a Power
Macintosh 8600/200 and processed through the Biotoolbox 2.2 software
from Sciex.
N-Deoxyribosyltransferase Assay--
The standard reaction
mixture contained 3 µmol of the deoxyribonucleoside donor and 1 µmol of the base acceptor in 20 mm of citrate buffer, pH 6.0, and the
appropriate number of enzyme units to hydrolyze 1 µmol of the
deoxyribonucleoside donor per minute. Reactions were incubated at
40 °C. After 15 and 30 min, 15-µl aliquots were added to 30 µl
ethanol, and the mixture was heated at 95 °C for 5 min. Samples were
then diluted with water and frozen before lyophilization The products
of the reactions were analyzed by high performance liquid
chromatography using a reverse-phase column (100-5C18) with a flow
rate of 1 ml/min and a linear gradient of 5-25% CH3CN (or
5-15% CH3CN in the case of purine exchange) in 10 mM triethylammonium acetate, pH 7.5, buffer for 20 min.
A Unique Genetic Selection for Cloning the Genes Coding for the Two
Classes of N-Deoxyribosyltransferases: Construction of a Guanine
Auxotrophic E. coli Strain Unable to Grow with Deoxyguanosine as a
Source of Guanine--
A functional screen allowing selection for the
production of guanine was established in E. coli. The two
genes of the guaBA operon code for IMP dehydrogenase and for
GMP synthetase, respectively, which govern the conversion of IMP to
xanthosine 5'-phosphate and to GMP. These genes were deleted
along with the genes of the deoCABD operon involved in the
catabolism of nucleosides. In the resulting strain, designated PAK6,
GMP can only be synthesized from guanine by the product of the
gpt gene coding for the guanine phosphoribosyltransferase,
because the purine nucleoside phosphorylase coded by the
deoD gene of the deoCABD operon was deleted (Fig. 1A). The PAK6 strain is
auxotrophic for guanine (G) and this requirement cannot be satisfied by
deoxyguanosine (dR-G); only a residual growth was observed (Fig.
2). This could be due to the xanthosine phosphorylase (coded by xapA) activity, which, like other
purine nucleoside phosphorylases, is able to carry out both
phosphorolysis and synthesis of purine deoxy- and
ribonucleosides (22). Deoxyguanosine (dR-G) will be a source of guanine
only if a N-deoxyribosyltransferase activity is expressed in
strain PAK6. Because both class I and class II
N-deoxyribosyltransferase catalyze the transfer of
deoxyribose between two purine bases, deoxyguanosine and adenine (A)
were chosen as substrates expecting the reaction, dR-G + A Functional Cloning of the ntd and ptd Genes--
A genomic bank of
L. helveticus CNRZ 32 DNA was constructed by inserting
AluI-restricted DNA fragments of 1 and 2 kb in size into the
SmaI site of the plasmid pBam3 (a ColE1 derivative of pBluescript). The ligation mixture was then transformed into strain PAK6. Colonies expressing a deoxyribosyltransferase activity were selected by their ability to grow on glucose mineral medium
supplemented with deoxyguanosine (dR-G) and adenine. Fig. 2 illustrates
the growth differences for PAK6 transformants expressing a
DRTase activity (Fig. 2, A and B, parts
b, c, and d) compared with the parent
(part a). To distinguish the two deoxyribosyltransferase activities, plasmid DNA from different selected colonies was extracted and used to transform the thymidine and guanine auxotrophic strain PAK26. In strain PAK26, dTMP cannot be synthesized from dUMP, because
the thymidylate synthase coded by thyA gene has been
inactivated. In addition, thymine cannot be a source of thymidine,
because the thymidine phosphorylase coded by deoA and the
uridine phosphorylase coded by udp genes have been deleted
(Fig. 1B) (22). Deoxyguanosine (dR-G) and thymine (T) will
be sources of guanine and thymidine only if a DRTase II activity is
expressed in strain PAK26 to catalyze the exchange reaction dG + T
Plasmid pLH4 contained a 1465-bp insert with two open reading frames
(GenBankTM accession number AY064166). The first one was
incomplete but displayed 38% identity with E. coli
adenosine deaminase. In particular, the His-197, Cys-245, Asp-278, and
Asp-279 residues that may participate to the catalytic site of
the E. coli deaminase (24) were also conserved in the
L. helveticus ADD-like sequence. The second open reading
frame separated by 52 bp from the first and located in the same
orientation was 501 bp long and coded for a 167-amino acids
polypeptide, designated PTD (for purine
trans-deoxyribosylase), with an apparent molecular
mass of 18,713 Da. PTD displayed 25% identity with NTD Lh.
Alignments of the four amino acid sequences with ClustalW 1.7 (Fig.
4) shows that the active site nucleophile
Glu-98 is conserved in the four sequences as well as residues Asp-72
and Asn-123, however, Asp-92 and Gln-46, involved in substrate binding,
are only found in three of the four sequences. This conservation
suggests a similar active site for the four proteins, although
structural differences must exist because pyrimidine is not a substrate
for PTD.
Overexpression and Purification of PTD and NTD--
To further
characterize the PTD and NTD enzymes, the two genes were amplified as
NdeI-BamHI fragments and cloned into the pET24a,
which has a T7 promoter inducible by
isopropyl-1-thio- Substrate Specificity and Activity--
PTD is a strict
purine-purine deoxyribosyltransferase, because no deoxyribose exchange
was detected with a purine base as donor and a pyrimidine base as
acceptor or with a pyrimidine base as donor and a purine or a
pyrimidine base as acceptor. Table III summarizes the specific
activities of PTD with the different purine couples. Specific
activities were approximately equal regardless of the purine pairs,
although a preference order of dI > dA > dG as
deoxyribonucleoside donor was observed. The purine Synthesis of Purine Nucleoside Analogues--
Most purine
nucleoside analogues synthesized enzymatically were prepared from
L. leichmannii and L. helveticus crude extracts or partially purified enzymes (26-29).
Having DRTase I and II purified, it was possible to evaluate the
activities of the two proteins for such analogues. 2-Aminopurine and 2,6-diaminopurine (Fig. 6) were
chosen as unnatural purines; 4-amino-5-carboxamide-imidazole (AICA) and
5-amicarboxamide imidazole (ICA) (Fig. 6), because they represent
simplified purines resulting from the opening of the six-membered ring
and elimination of C2 and N3 (AICA) and C2 (ICA). AICA and ICA were
converted to their deoxyribo derivative by using crude extracts from
L. leichmannii (30). 2-Aminopurine and 2,6-diaminopurine
were found to be converted to the corresponding deoxyribonucleoside at
a similar rate as canonical purine bases for both PTD and NTD. AICA and
ICA were poorer substrates. Their conversion to dR-AICA and dR-ICA
required more enzyme units and extended incubation times. In the four
transglycosylation reactions, the specific activity of PTD was higher
than that of NTD (data not shown).
The existence of two deoxyribosyltransferases in L. helveticus and L. leichmannii was suggested for a long time and
was only confirmed by the comparison of the first N-terminal amino
acids of the two L. leichmannii DRTases (15). Here, we
cloned the genes coding for these two types of activities by their
capacity to restore the guanine auxotrophy of an E. coli
strain unable to grow with deoxyguanosine as the source of guanine.
This genetic selection may be applied to clone genes coding for an
N-deoxyribosyltransferase or deoxyribosyl hydrolase from any
organism. Furthermore, the use of a double-guanine thymidine auxotroph
strain as a second screen allowed for discrimination between DRTase I
and DRTase II activities and rapid determination of their substrate
specificities. N-Deoxyribosyltransferase is not restricted
to Lactobacilli, because they were also found in some
Pediococcus, Aerococcus, Leuconostoc, and Streptococcus strains (31). Whether they contain the two types of activities remains unknown for the moment. A purine
trans-N-deoxyribosyltransferase similar to DRTase I was
purified from the protozoan parasite Crithidia luciliae (32,
33). Because this parasite does not synthesize purines de
novo and is deficient in adenosine deaminase, it was postulated
that the deoxyribosyltransferase may regulate the pool of nucleotides.
A similar role could be proposed for the L. helveticus or
L. Leichmannii deoxyribosyltransferases, because adenine was shown to inhibit cell growth. This might be related to adenine inhibition of the deoxyribose transfer reaction (34). If so, this would
explain the existence of two DRTases with different expression levels
and activities. Several lines of evidence suggest a specific role for
DRTase I in the eradication of deoxyinosine from the cellular
nucleoside pool by converting deoxyinosine to hypoxanthine, which can
then be recycled in IMP by hypoxanthine phosphoribosyltransferase and
to a DRTase I-deoxyribose complex that can be combined with another
purine. Indeed, the specific activity of PTD was more than 20 times
higher than that of NTD when deoxyinosine was the donor substrate. Such
a difference of activity was not observed with deoxyguanosine as donor.
Furthermore, hypoxanthine, compared with the other bases, is not a good
substrate for NTD but is a substrate for PTD and hypoxanthine
phosphoribosyltransferase. Another argument in favor of a specific role
for PTD in the eradication of dI is brought by the colocalization of
its gene (ptd) with the add gene (coding for
adenosine deaminase) on the same DNA fragment, suggesting a link in
their function. Adenosine deaminase catalyzes the deamination of
adenosine and deoxyadenosine to inosine and deoxyinosine, respectively.
Thus, in the lactobacilli having a requirement for bases and
deoxyribonucleosides for growth, in the absence of a purine
trans-deoxyribosylase, deoxyinosine would not be catabolized
efficiently by NTD alone (in these strains, nucleoside phosphorylase,
nucleoside hydrolase, phosphopentomutase, and deoxyriboaldolase are
absent). dI would then be subject to phosphorylation by a purine
deoxyribonucleoside kinase. Deoxyribonucleoside kinases have not yet
been characterized in L. helveticus, but they have been
identified in the closely related species L. leichmannii and
L. acidophilus (35, 36). These lactobacilli possess kinases for the four deoxyribonucleosides and in L. acidophilus
R-26, three of the four activities are organized into two
heterodimers deoxyadenosine/deoxycytidine kinase and
deoxyadenosine/deoxyguanosine kinase (36). This latter enzyme could
phosphorylate deoxyinosine to give dIMP, similar to the Bacillus
subtilis deoxyguanosine kinase (37), which in turn would be
converted to dITP through the successive action of guanylate kinase and
nucleoside diphosphate kinase. Incorporation of dITP into DNA would be
mutagenic and consequently detrimental for the cell. Thus, the
necessity of two deoxyribosyltransferases, one with deoxyinosine
specificity and closely linked to the level of adenosine deaminase,
would favor the eradication of dI and prevent its incorporation into DNA.
The comparison of the amino acids sequences of DRTases I and II
revealed a low degree of conservation. The crystal structure of
L. leichmannii NDT and two ligand-bound forms of the enzyme have been determined (13). Structural and biochemical data indicate that Glu-98 is the nucleophile (12, 14) and that Gln-46, Asp-72, and
Asp-92 may be involved in substrate binding. These residues, with the
exception of Gln-46, are also found in the PTD sequence. Gln-46
(replaced by a glycine residue in PTD) was proposed to make two
hydrogen bonds with a pyrimidine substrate and one with a purine (13).
Thus, the substitution of Gln-46 by Gly could explain why DRTase I is
unable to transfer deoxyribose between a purine base as donor and a
pyrimidine base as acceptor. Neither mutagenesis of the Gly residue to
Gln nor the random mutagenesis of the whole gene converted the DRTase I
activity to that of DRTase II (data not shown). Thus, this conversion
likely requires extensive structural changes, because a single amino
acid change was not sufficient. However, PTD represents an alternative
to NTD and to purine nucleoside phosphorylase for the enzymatic
synthesis of purine nucleoside analogues, considering its substrate
specificity and its activity. Crystallization of PTD with different
ligands and comparison with the NDT structure should provide a more
complete picture of the enzymes reaction mechanism, the residues
involved in purine and pyrimidine binding, and the basis of its
substrate specificity. The combination of structural studies and
genetic selection should help to improve the NDT enzyme as a
biocatalyst for nucleoside synthesis.
I thank P. Tailliez, R. Cotaya for L. helveticus cultures, S. Perrier for technical assistance in
protein purification, O. Helynck for high performance liquid
chromatography, S. Pochet for helpful discussions, and D. M. Rowe
for critical reading and correction of the manuscript.
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Published, JBC Papers in Press, February 8, 2002, DOI 10.1074/jbc.M111995200
The abbreviations used are:
NDT, L.
leichmannii DRTase II;
TES, 2-{[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]amino}ethanesulfonic
acid;
PTD, purine trans-deoxyribosylase;
dI, deoxyinosine;
dG, deoxyguanosine;
Hx, hypoxanthine;
AICA, 4-amino-5-carboxamide-imidazole;
ICA, 5-amicarboxamide imidazole;
IMP, inosine-5'-phosphate;
dITP, deoxyinosine triphosphate.
Functional Cloning, Heterologous Expression, and Purification of
Two Different N-Deoxyribosyltransferases from
Lactobacillus helveticus*
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
Pur), and DRTase II, catalyzing the
transfer of deoxyribose to and from purine and pyrimidine (Pur
Pur,
Pur
Pyr, and Pyr
Pyr) (4). These transfer reactions, catalyzed
by either DRTase I or DRTase II, follow a ping pong bi-bi mechanism in
which the cleavage of the N-glycosidic bond of a
2'-deoxyribonucleoside results in the formation of a covalent
deoxyribosyl-enzyme intermediate (5, 6). In addition to its transferase
activity, the Lactobacillus leichmannii DRTase II, also
called NDT,1 has a hydrolase
function such that in the absence of an acceptor base the nucleoside is
converted to its base and deoxyribose (7). The low specificity of
DRTase II toward the acceptor base (8) in addition to the
stereospecificity of the glycosyltransfer (only the
anomer of the
nucleoside is formed) have been exploited to synthesize a large number
of nucleoside analogues from L. helveticus or L. leichmannii crude extracts, among them some with antiviral or
anticancer properties (9-11).
gua
deo E. coli strain with deoxyguanosine as the
source of guanine. DRTase I and II from L. helveticus were overexpressed in E. coli and further purified. Their
activities were measured with canonical nucleosides and bases and with
a few purine analogues as base acceptors.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
Strains and plasmids used
guaBA::gm,
deo-11--
Oligonucleotides gua1
(5'-NGAATTCGTTGACGGGTCGATTGCACC-3') and gua4
(5'-NNGGATCCTGTCTTCTGCCTGTGGCAATG-3') were used to amplify in a
standard PCR reaction a 5.2-kb DNA fragment containing the guaB and guaA genes from E. coli
MG1655 DNA. The PCR reaction contained 100 pmol of each nucleotide, 100 ng of DNA template, 200 µM dNTPs, 2.5 units of
Taq DNA polymerase (Roche Molecular Biochemicals), and 2.5 units of Pfu polymerase (Stratagene) in a volume of 100 µl. The parameters used were 1 cycle of 5 min at 95 °C, 25 cycles
with three steps (30 s at 95 °C, 30 s at 60 °C, 3 min at
72 °C), and 1 cycle of 10 min at 72 °C. The PCR product was
cloned into plasmid pCR2.1-T0P0 (Invitrogen), and the mixture was used
to transform strain TOP10F' (Invitrogen). Plasmid DNA from
several transformants was prepared and used as DNA template in a
PCR reaction with oligonucleotides gua2
(5'-NNNNCCCGGGCAATATCTCGACCAGAGTGG-3') and gua3
(5'-NNNNCCCGGGTTTGACCCTGCACTATGAATG-3'). The
parameters were 1 cycle of 5 min at 95 °C, 30 cycles with three
steps (30 s at 95 °C, 30 s at 62 °C, 4 min at 72 °C), and
1 cycle of 10 min at 72 °C. The resulting PCR product was digested
with restriction enzyme SmaI (underlined in the sequences of
oligonucleotides gua2 and gua3), purified after migration on an agarose
gel with the Qiagel extraction kit, and ligated to a 1.1-kb
SmaI DNA fragment conferring resistance to gentamicin. The
ligation mixture was used to transform strain
2033. Plasmid DNA
from several gentamicin-resistant transformants was prepared and used
in a PCR reaction with oligonucleotides gua1 and gua4. The resulting
PCR product was then purified from an agarose gel and digested for
12 h at 37 °C with the restriction enzyme DpnI.
After a phenol extraction, the PCR product was precipitated with
ethanol. The DNA obtained after centrifugation was resuspended in water
and used to transform by electroporation according to Dower et
al. (18) strain MG1655 carrying the pKOBEG plasmid (19).
Transformants were selected on LB medium supplemented with
gentamicin (10 µg/ml) and guanine (0.3 mM).
Guanine auxotrophs that were selected by plating on the same medium
without addition of guanine had deletions of the guaB and
guaA genes. This strain was designated PAK4. The
serB::Tn10 mutation carried by strain KU8 (20) was transduced into strain PAK4 with the help of phage P1 to
give strain PAK5. PAK6 was obtained after transduction by a P1 phage
stock prepared from strain Sø 928 (21) and selecting for
tetracycline-sensitive colonies.
guaBA::gm,
deo-11,
thyA::erm,
(udp-metE)
zif9::Tn10--
The
deo-11 deletion was
introduced into strain
1308 by two successive P1 transductions as
above. The
deo-11,
thyA::erm,
(udp-metE)
zif9::Tn10 was obtained after a
P1 transduction of the
deo-11,
thyA::erm strain with a stock
prepared from strain AM2D9 by selecting for resistance to tetracycline.
The PAK26 strain was obtained after transduction of the
guaBA deletion with a P1 stock prepared from strain PAK6.
Strain PAK26 was auxotrophic for methionine, guanine, and thymidine.
2033. Plasmids containing an insert of the correct size were sequenced by
MWG-Biotech. Those with the correct sequence, pETLH2 and pETLH4, were
used to transform strain BL21(DE3)pLysS (Novagen).
-D-galactopyranoside was added to a
final concentration of 0.4 mM, and the cultures were
incubated for 2.5 h. Bacteria were centrifuged, washed once with a
100 mM phosphate buffer
(NaH2PO4/Na2HPO4, pH
7.5). Pellets were frozen at
20 °C. Cells were resuspended in 20 ml of phosphate buffer and broken by one passage through a French press
at 14000 p.s.i. The lysate was centrifuged at 50,000 rpm for 1 h,
and the supernatant was precipitated by addition of solid ammonium
sulfate to 55% saturation. Proteins were pelleted by centrifugation at 18,000 rpm for 30 min and resuspended in phosphate buffer. Each protein
was further purified by filtration on a Sephacryl S-200 column
previously equilibrated with 0.1 M NaCl. The elution was followed by UV absorption at 280 nm, and each fraction was analyzed by
SDS-PAGE electrophoresis and by following the transfer activity. The
most pure and active fractions were dialyzed against 100 mM citrate, pH 6.0, buffer. Protein concentration was measured by the
Bradford assay using bovine serum albumin as the standard.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
dR-A + G.

View larger version (12K):
[in a new window]
Fig. 1.
Schematic representation of the salvage
pathways in E. coli. A, purine. The enzymes of
the pathway are represented by their gene names: guaB, IMP
dehydrogenase; guaA, GMP synthetase; guaC, GMP
reductase; gpt, guanosine phosphoribosyltransferase;
hpt, hypoxanthine phosphoribosyltransferase; gsk,
guanosine kinase; deoD, purine nucleoside phosphorylase;
deoB, phosphopentomutase; deoC,
deoxyriboaldolase. X, xanthine, G, guanine;
rG, guanosine; dG, deoxyguanosine;
DR-1P, deoxyribose 1-phosphate; DR-5P,
deoxyribose 5-phosphate. B, pyrimidine. thyA,
thymidilate synthase; tdk, thymidine kinase;
deoA, thymidine phosphorylase; udp, uridine
phosphorylase; upp, uracil phosphoribosyltransferase;
udk, uridine kinase; cdd, cytidine deaminase;
codA, cytosine deaminase; U, uracile;
C, cytosine; T, thymine; dU,
deoxyuridine; dT, deoxythymidine; dC,
deoxycytidine; rU, uridine; rC, cytidine.

View larger version (71K):
[in a new window]
Fig. 2.
Requirement of a deoxyribosyl hydrolase
activity for PAK6 (
guaBA::gm,
deo-11) growth. Colonies were first
isolated on glucose mineral medium supplemented with chloramphenicol
(25 µg/ml) and guanine (0.3 mM) and then streaked on
either the same medium (A) or on glucose mineral medium
supplemented with ampicillin (100 µg/ml), deoxyguanosine (0.3 mM), and adenine (0.3 mM) (B).
Plates were incubated 48 h at 37 °C. a, PAK6
carrying pBam3 plasmid; b, PAK6 carrying pLH2 plasmid
(L. helveticus ntd); c, PAK6 carrying pLH4
plasmid (L. helveticus ptd); d, PAK6 carrying pLL
plasmid (L. leichmannii ntd).
dT + G. Only colonies expressing a DRTase II activity can grow
on glucose mineral medium supplemented with deoxyguanosine and thymine
as sources of guanine and thymidine (Fig.
3, A and B,
parts b and d). This second screening allowed the
correlation of DRTase II activity with plasmid pLH2 and DRTase I with
plasmid pLH4. To confirm the in vivo activities, in
vitro, cell-free extracts from strains PAK6, PAK6 pLH2, and PAK6
pLH4 were prepared. As expected from the in vivo selection,
extracts from strain PAK6 pLH4 could transfer the 2'-deoxyribose
between guanine and adenine but not between cytosine and thymine or
cytosine and adenine (Table II). This was
in contrast to extracts of PAK6 pLH2 and PAK6 pLL (pLL contains the
L. leichmannii ntd gene under the control of the
lac promoter) clearly indicating that pLH4 codes for DRTase
I. The inserts of plasmids pLH2 and pLH4 were sequenced. Plasmid pLH2
contained a 1286-bp insert. A 474-bp open reading frame
(GenBankTM accession number AY064167) beginning at
position 209 relative to the insertion site was identified. This open
reading frame coded for a 158-amino acid polypeptide of 18,148 Da,
designated NTD Lh with 83 and 81% identity with the corresponding
N-deoxyribosyltransferase from L. helveticus ATCC
8018 (23) and L. leichmannii (14). NTD is probably expressed
from its own promoter as predicted by Neural Network Promoter
Prediction. No other significant homology was found in the data bank
for the 1-kb DNA fragment following ntd.

View larger version (64K):
[in a new window]
Fig. 3.
Requirement of a
N-deoyribosyltransferase activity for PAK26
(
guaBA::gm
deo-11
thyA::erm
(udp-metE)
zif9::Tn10) growth.
Colonies were first isolated on glucose mineral medium
supplemented with ampicillin (100 µg/ml), thymidine (0.3 mM), and guanine (0.3 mM) and then streaked on
either the same medium (A) or on glucose mineral medium
supplemented with ampicillin (100 µg/ml), deoxyguanosine (0.3 mM), and thymine (0.3 mM). Plates were
incubated 48 h at 37 °C. a, PAK6 carrying pBam3
plasmid; b, PAK6 carrying pLH2 plasmid (L. helveticus
ntd); c, PAK6 carrying pLH4 plasmid (L. helveticus ptd); d, PAK6 carrying pLL plasmid (L. leichmannii ntd).
Growth of strain PAK6 carrying different plasmids on glucose mineral
medium (in vivo) and enzymatic activity of the corresponding crude
extracts (in vitro)
indicates no growth, ± residual growth;
in vitro: + and
indicate the formation of
deoxynucleoside (dN) in the reaction dX + N
dN + X.

View larger version (32K):
[in a new window]
Fig. 4.
Amino acids sequences alignment of
lactobacilli deoxyribosyltransferases. Sequences were aligned
using the ClustalW 1.7 program. NTDLh, L. helveticus CNRZ32 ntd; NTDLhj, L. helveticus ATCC 8018 ntd; NTDLl, L. leichmannii ntd; PTDLh, L. helveticus CNRZ32
ptd. The asterisk indicates positions that have a
single, fully conserved residue; the colon (:) indicates
that one of the following groups is fully conserved: AST, NEQK, NHQK,
NDEQ, QHRK, MILV, MILF, HY, FYW; the dot (.) indicates that
one of the following groups is fully conserved: CSA, ATV, SAG, STNK,
STPA, SGND, SNDEQK, NDEQHK, NEQHRK, FVLIM, HFY. The active-site
nucleophile Glu-98 is indicated in boldface as well as
Gln-46, Asp-72, Asp-92, and Asn-123 residues involved in substrate
binding.
-D-galactopyranoside. The
ptd gene was expressed at a high level and purified by
ammonium sulfate fractionation (Fig.
5A, lane 2) and gel
filtration (Fig. 5A, lane 3) to homogeneity as
judged by SDS-PAGE. By comparison, the ntd gene seemed to be
expressed at a lower level. The purification was not as homogenous as
for PTD, because a polypeptide of about 32 kDa was still present (Fig.
5B). Homogeneity could be obtained after a short incubation
at 65 °C, which denatured the 32-kDa polypeptide without affecting
the NTD activity (data not shown). Both PTD and NTD have a similar
apparent molecular mass of 24 kDa, a higher value than the deduced
18-kDa molecular mass. However their molecular mass estimated by
electrospray ionization mass spectrometry (18,712.91 ± 0.84 and
18,149.10 ± 1.58) was in agreement with that calculated from the
sequence (18,713.18 and 18,148.57). As estimated by their elution
volume during the gel filtration both proteins should be hexameric,
which is in agreement with previous reports (15, 25).

View larger version (66K):
[in a new window]
Fig. 5.
Purification of L. heveticus
PTD and NTD. A, different steps of the
purification of PTD. Lane 1, 10 µg of total proteins after
lysis of BL21(DE3)pLysS pETLH4 cells and centrifugation. Lane
2, 10 µg of proteins after precipitation with 55% ammonium
sulfate. Lane 3, 10 µg of proteins after gel filtration on
Sephacryl S-200 column. B, 2.5 µg of proteins from
BL21(DE3)pLysS pETLH2 cells after lysis, centrifugation ammonium
precipitation, and gel filtration. Samples were separated on a 12%
SDS-PAGE stained with Coomassie Blue. Molecular weight markers on the
left side of each gel (Prestained SDS-PAGE standards low
range from Bio-Rad) contained phosphorylase B (116 kDa), bovine serum
albumin (80 kDa), ovalbumin (52.5 kDa), carbonic anhydrase (34.9 kDa),
soybean trypsin inhibitor (29.9 kDa), and lysozyme (21.8 kDa).
purine activity
of PTD was at least 20 times higher than that of NTD, if one considers
the dI + A
dA + I exchange reaction (82.8 units/mg versus 3 units/mg). However, deoxyinosine (dI) does not
seem to be a very good substrate for NTD, because the difference of
purine
purine activity between NTD and PTD was significantly
reduced when deoxyguanosine (dG) was used as deoxynucleoside donor.
Furthermore, although hypoxanthine (Hx) was as good as guanine or
adenine as acceptor base for PTD, it was a bad substrate for NTD
whatever the deoxyribonucleoside donor (Tables III and
IV). As previously shown for purified NTD
from L. leichmannii, pyrimidine deoxyribonucleosides and
purine bases seemed to be the preferred substrates for L. helveticus NTD (Table IV).
Specific activities of the L. helveticus purine transdeoxyribosylase
PTD
Specific activities of the L. helveticus the N-deoxyribosyltransferase
NTD

View larger version (14K):
[in a new window]
Fig. 6.
Examples of purine nucleoside analogues as
base acceptor for NTD and PTD.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
To whom correspondence should be addressed. Tel.: 33-14-061-3052;
Fax: 33-14-568-8404; E-mail: akaminsk@pasteur.fr.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Hammer-Jespersen, K.
(1983)
in
Metabolism of Nucleotides, Nucleosides and Nucleobases in Microorganisms
(Munch-Petersen, A., ed)
, pp. 244-245, Academic Press Inc, London
2.
MacNutt, W. S.
(1952)
Biochem. J.
50,
384-397[Medline]
[Order article via Infotrieve] 3.
Roush, A. H.,
and Betz, R. F.
(1958)
J. Biol. Chem.
233,
261-266 4.
Holguin, J.,
and Cardinaud, R.
(1975)
Eur. J. Biochem.
54,
505-514[Medline]
[Order article via Infotrieve] 5.
Danzin, C.,
and Cardinaud, R.
(1974)
Eur. J. Biochem.
48,
255-262[Medline]
[Order article via Infotrieve] 6.
Danzin, C.,
and Cardinaud, R.
(1976)
Eur. J. Biochem.
65,
365-372[CrossRef][Medline]
[Order article via Infotrieve] 7.
Smar, M.,
Short, S. A.,
and Wolfenden, R.
(1991)
Biochemistry
30,
7908-7912[CrossRef][Medline]
[Order article via Infotrieve] 8.
Cardinaud, R.,
and Holguin, J.
(1979)
Biochim. Biophys. Acta
568,
339-347[Medline]
[Order article via Infotrieve] 9.
Carson, D. A.,
and Wasson, D. B.
(1988)
Biochem. Biophys. Res. Commun.
155,
829-834[CrossRef][Medline]
[Order article via Infotrieve] 10.
Freeman, G. A.,
Shaver, S. R.,
Rideout, J. L.,
and Short, S. A.
(1995)
Bioorg. Med. Chem.
3,
447-458[CrossRef][Medline]
[Order article via Infotrieve] 11.
Hicks, N.,
Hutchinson, D. W.,
Mahmood, N.,
and Hay, A. J.
(1992)
Antiviral Chem. Chemother.
3,
153-156 12.
Porter, D. J.,
and Short, S. A.
(1995)
J. Biol. Chem.
270,
15557-15562 13.
Armstrong, S. R.,
Cook, W. J.,
Short, S. A.,
and Ealick, S. E.
(1996)
Structure
4,
97-107[Medline]
[Order article via Infotrieve] 14.
Porter, D. J.,
Merrill, B. M.,
and Short, S. A.
(1995)
J. Biol. Chem.
270,
15551-15556 15.
Becker, J.,
and Brendel, M.
(1996)
Biol. Chem. Hoppe-Seyler
377,
357-362[Medline]
[Order article via Infotrieve] 16.
Richaud, C.,
Mengin-Lecreulx, D.,
Pochet, S.,
Johnson, E. J.,
Cohen, G. N.,
and Marliere, P.
(1993)
J. Biol. Chem.
268,
26827-26835 17.
Miller, J. H.
(1972)
Experiments in Molecular Genetics
, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
18.
Dower, W. J.,
Miller, J. F.,
and Ragsdale, C. W.
(1988)
Nucleic Acids Res.
16,
6127-6145 19.
Chaveroche, M. K.,
Ghigo, J. M.,
and d'Enfert, C.
(2000)
Nucleic Acids Res.
28,
E97 20.
Uhland, K.,
Ehrle, R.,
Zander, T.,
and Ehrmann, M.
(1994)
J. Bacteriol.
176,
4565-4571 21.
Valentin-Hansen, P.,
Svenningsen, B. A.,
Munch-Petersen, A.,
and Hammer-Jespersen, K.
(1978)
Mol. Gen. Genet.
159,
191-202[CrossRef][Medline]
[Order article via Infotrieve] 22.
Hammer-Jespersen, K.,
Buxton, R. S.,
and Hansen, T. D.
(1980)
Mol. Gen. Genet.
179,
341-348[CrossRef][Medline]
[Order article via Infotrieve] 23.
Okuyama, K.,
and Noguchi, T.
(2000)
Biosci. Biotechnol. Biochem.
64,
2243-2245[CrossRef][Medline]
[Order article via Infotrieve] 24.
Chang, Z. Y.,
Nygaard, P.,
Chinault, A. C.,
and Kellems, R. E.
(1991)
Biochemistry
30,
2273-2280[CrossRef][Medline]
[Order article via Infotrieve] 25.
Cook, W. J.,
Short, S. A.,
and Ealick, S. E.
(1990)
J. Biol. Chem.
265,
2682-2683 26.
Betbeder, D.,
Hutchinson, D. W.,
and Richards, A. O.
(1989)
Nucleic Acids Res.
17,
4217-4222 27.
Betbeder, D.,
and Hutchinson, D. W.
(1990)
Nucleosides & Nucleotides
9,
569-578 28.
Huang, M. C.,
Hatfield, K.,
Roetker, A. W.,
Montgomery, J. A.,
and Blakley, R. L.
(1981)
Biochem. Pharmacol.
30,
2663-2671[CrossRef][Medline]
[Order article via Infotrieve] 29.
Huang, M. C.,
Montgomery, J. A.,
Thorpe, M. C.,
Stewart, E. L.,
Secrist, J. A., 3rd,
and Blakley, R. L.
(1983)
Arch. Biochem. Biophys.
222,
133-144[CrossRef][Medline]
[Order article via Infotrieve] 30.
Pochet, S.,
Dugué, L.,
Meier, A.,
and Marlière, P.
(1995)
Biorg. Med. Chem. Lett.
5,
1679-1684[CrossRef] 31.
Chawdhri, R. F.,
Hutchinson, D. W.,
and Richards, A. O.
(1991)
Arch. Microbiol.
155,
409-411 32.
Steenkamp, D. J.
(1991)
Eur. J. Biochem.
197,
431-440[Medline]
[Order article via Infotrieve] 33.
Steenkamp, D. J.,
and Halbich, T. J.
(1992)
Biochem. J.
287,
125-129 34.
Beck, W. S.,
and Levin, M.
(1963)
J. Biol. Chem.
238,
702-709 35.
Powell, J. W.,
and Wachsman, J. T.
(1973)
Appl. Microbiol.
25,
869-872[Medline]
[Order article via Infotrieve] 36.
Ives, D. H.,
and Ikeda, S.
(1998)
Prog. Nucleic Acid Res. Mol. Biol.
59,
205-255[Medline]
[Order article via Infotrieve] 37.
Andersen, R. B.,
and Neuhard, J.
(2001)
J. Biol. Chem.
276,
5518-5524 38.
Lemeignan, B.,
Sonigo, P.,
and Marliere, P.
(1993)
J. Mol. Biol.
231,
161-166[CrossRef][Medline]
[Order article via Infotrieve]
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
P. A. Kaminski, P. Dacher, L. Dugue, and S. Pochet In Vivo Reshaping the Catalytic Site of Nucleoside 2'-Deoxyribosyltransferase for Dideoxy- and Didehydronucleosides via a Single Amino Acid Substitution J. Biol. Chem., July 18, 2008; 283(29): 20053 - 20059. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Pettersson, M. E. Schrumpf, S. J. Raffel, S. F. Porcella, C. Guyard, K. Lawrence, F. C. Gherardini, and T. G. Schwan Purine Salvage Pathways among Borrelia Species Infect. Immun., August 1, 2007; 75(8): 3877 - 3884. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. V. Smeianov, P. Wechter, J. R. Broadbent, J. E. Hughes, B. T. Rodriguez, T. K. Christensen, Y. Ardo, and J. L. Steele Comparative High-Density Microarray Analysis of Gene Expression during Growth of Lactobacillus helveticus in Milk versus Rich Culture Medium Appl. Envir. Microbiol., April 15, 2007; 73(8): 2661 - 2672. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. K. Ghiorghi, K. I. Zeller, C. V. Dang, and P. A. Kaminski The c-Myc Target Gene Rcl (C6orf108) Encodes a Novel Enzyme, Deoxynucleoside 5'-monophosphate N-Glycosidase J. Biol. Chem., March 16, 2007; 282(11): 8150 - 8156. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||